Estrogen receptor protein in breast cancer as a predictor of recurrence
- 15 May 1981
- Vol. 47 (10), 2364-2367
- https://doi.org/10.1002/1097-0142(19810515)47:10<2364::aid-cncr2820471007>3.0.co;2-s
Abstract
Estrogen receptor protein (ERP) determinations of primary cancers of 1034 patients with primary breast cancer were done. ERP-positive patients tended to have a lower recurrence rate and had significantly improved survival. This difference was most apparent in patients with four or more axillary nodes involved. ERP-positive patients who recurred had a better survival. ERP did not influence response to adjuvant chemotherapy, nor did the presence of progesterone receptor or femtomole level of ERP affect recurrence.This publication has 5 references indexed in Scilit:
- The relative importance of estrogen receptor analysis as a prognostic factor for recurrence or response to chemotherapy in women with breast cancerCancer, 1980
- Correlation between estrogen receptor protein and carcinoembryonic antigen in normal and carcinomatous human breast tissue.Clinical Chemistry, 1976
- Estrogen Receptor and Natural Course of Breast CancerAnnals of Surgery, 1976
- A generalized Kruskal-Wallis test for comparing K samples subject to unequal patterns of censorshipBiometrika, 1970